Movement Alert|Guardant Health Inc. falls 4.75% in Regular Trading, convertible note settlement weighs on shares

Market Focus11-16

On November 16, Guardant Health Inc. fell 4.75% in Regular Trading, trading at $147.33/share, with turnover of $33.93 million.

The clearest catalyst is the settlement of the company’s $500.0 million zero-coupon convertible senior notes due 2032, which has renewed investor focus on potential future conversion dilution and financing overhang.

Company disclosures show expected net proceeds of about $538.3 million if the full option is exercised. Guardant Health Inc. plans to use about $501.7 million to repurchase roughly $395.2 million principal amount of its 2027 zero-coupon convertible notes, while the remaining proceeds together with cash on hand will fund about $51.7 million of capped call transactions intended to offset dilution from future note conversion. The transaction improves debt maturity profile, but the market reaction has been cautious despite that liability-management benefit.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment